Differentially expressed gene products in glioblastoma cells suppressed for tumorigenicity

Journal of NeuroVirology

Volumn 4, Issue 2, 1998, Pages 217-226

  Ligon, Azra H ^a,b,c   Pershouse, Mark A ^a   Jasser, Samar ^a   Hong, Yong Kil ^a,d   Yung, W K Alfred ^a   Steck, Peter A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Department of Pathology ^*  (United States)

^d The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Chromosome 10; Differential gene expression; MMAC1; Tumor suppression

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; INSULIN RECEPTOR; PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR A;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CARCINOGENICITY; CELL DENSITY; CELL DIFFERENTIATION; CELL STRUCTURE; CHROMOSOME 10; CONTROLLED STUDY; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HYBRID CELL; MOLECULAR CLONING; NUDE MOUSE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

EID: 0031960884     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809114521     Document Type: Article

References (41)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990). Basic local alignment search tool. J Mol Biology 215: 403-410.
2. Aviv H, Leder P (1972). Purification of biologically active globin messenger RNA by chromatography on oligothymidilic acid-cellulose. Proc Natl Acad Sci USA 69: 1408-1412.
3. Bigner SH, Mark H, Burger PC, Mahaley MS, Bullar DE, Mughlbaier LH, Bigner DD (1988). Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 88: 405-411.
4. Bigner SH, Mark J, Bigner DD (1990). Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47: 141-154.
5. Chirgwin JJ, Przbyla AE, MacDonald RJ, Rutter WJ (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemstry 18: 52-94.
6. Connor JR, Boeshore KL, Benkovic SA, Menzies SL (1994). Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res 37: 461-465.
7. Davis MM (1986). Subtractive cDNA hybridization and the T-cell receptor genes. In: Handbook of Experimental Immunology, DM Weir, LA Herzenberg, C Blackwell, LA Herzenberg (eds.), Vol.2, pp. 76.1-76.13.
8. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993). WAF1, A potential mediator of p53 tumor suppression. Cell 75: 817-825.
9. Feinberg A, Vogelstein B (1984). A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13.
10. Fults D, Pedone CA (1992). Deletion mapping of the long arm of chromosomes 10 in glioblastoma multiforme. Genes Chromom Cancer 7: 173-177.
11. Fults D, Pedone CA, Thomas GA, White R (1990). Allelotype of human malignant astrocytoma. Cancer Res 50: 5784-5789.
12. Fults D, Petronio J, Noblett BD, Pedone CA (1992). Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors. Genomics 14: 799-801.
13. Fults D, Tippets RH, Thomas GA, Nakamura Y, White R (1989). Loos of heterozygosity for loci on chromosome 17p in human malignant astrocytomas. Cancer Res 49: 6572-6577.
14. Hsu SC, Volpert OV, Steck PA, Mikkelsen T, Polverini PJ, Rao S, Chou P, Bouck NP (1996). Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 56: 5684-5691.
15. James CD, He J, Carlbom E, Nordenskjold M, Cavenee WK, Collins VP (1991). Chromosomes 9 deletion mapping reveals interferon α and Interferon β-1 gene deletions in human glial tumors. Cancer Res 51: 1684-1688.
16. James D, Carlbom E, Dumanski J, Hansen M, Nordenskjold M, Collins VP, Cavanee W (1988). Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546-5551.
17. Khan AS, Wilcox AS, Polymeropoulos MH, Hopkins JA, Stevens TJ, Robinson M, Orpana AK, Sikela JM (1992). Single pass sequencing and physical and genetic mapping of human brain cDNAs. Nature Genetics 2: 180-185.
18. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibhoosh H, Wigler MH, Parsons R (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
19. Ligon AH, Pershouse MA, Jasser SA, Yung WKA, Steck PA (1997). Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma. Oncogene 14: 1075-1081.
20. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, Poutska A (1997). DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nature Genetics 17: 32-39.
21. Myers MP, Stolarov JP, Eng C, Li J, Wagner I, Wigler MH, Parsons R, Tonks NK (1997). P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: 9052-9057.
22. Nister M, Hammacher A, Mellstrom K, Siegbahn A, Ronnstrand L, Westermark B, Heldin C-H (1988). A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell 52: 791-799.
23. Pang JCS, Du RP, Bingham H, Juranka P, Chan V-L (1989). Imbalance of purine nucleotides in alanosine-resistant baby hamster kidney cells. Somatic Cell Mol Genet 15: 101-111.
24. Pershouse MA, Stubblefield E, Hadi A, Killary AM, Yung WKA, Steck PA (1993). Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res 53: 5043-5050.
25. Pringle N, Collarini EJ, Mosely MJ, Heldin C-H, Westermark B, Richardson WD (1989). PDGF A chain homodimers drive proliferation of bipotential (O-2A) glial progenitor cell in the developing rat optic nerve. EMBO J 8: 1049-1056.
26. Raff MC, Miller RH, Noble M (1983). A glial progenitor cell that develops in vitro into an astroctye or an oligodendrocyte depending on culture medium. Nature (Lond) 274: 813-816.
27. Ransom DT, Ritland SR, Kimmel DVV, Moertel CA, Dahl RJ, Scheithauer BW, Kelly PJ, Jenkins RB (1992). Cytogenetic and loss of heterozygositv studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas Genes Chromosom Cancer 5: 348-356.
28. Rasheed BKA, Fuller GN, Friedman AH, Bigner DD, Bigner SH (1992). Loss of heterozygosity for 10q loci in human gliomas. Genes Chromom Cancer 5: 75-82.
29. Rasheed BKA, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Biger DD, Bigner SH (1995). Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 12: 2244-2247.
30. Ritland SR, Ganju V, Jenkins RB (1995). Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosom Cancer 12: 277-282.
31. Sambrook J, Fritsch EF, Maniatis T (1989). In Molecular Cloning: A Laboratory Manual. Second Edition, Cold Spring Harbor Laboratory Press.
32. Sharp MGF, Admas SM, Walker RA, Brammar WJ, Varley JM (1992). Differential expression of the mitochondrial gene cytochrome oxidase II in benign and malignant breast tissue. J Pathology 168: 163-168.
33. Steck PA, Ligon AH, Cheong P, Yung WKA, Pershouse MA (1995). Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromsom Cancer 12: 255-261.
34. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Fyre C, Hu R, Swedlund B, Teng DHF, Tavtigian S (1997). Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics 15: 356-362.
35. Stehelin D, Guntaka RV, Varmus HE, Bishop JM (1976). Purification of DNA complementary to nucleotide sequences required for neoplastic transformation of fibroblasts by avian sarcoma viruses. J Mol Biol 101: 349-365.
36. Stubblefield E, Pershouse M (1992). Direct formation of microcells from mitotic cells for use in chromosome transfer. Somatic Cell Mol Genet 18: 485-491.
37. Vayssiere J-C, Cordeau-Lossouarn L, Larcher JC, Basseville M, Gros F, Croizal B (1994). Participation of the mitochondrial genome in the differentiation of neuroblastoma cells. In Vitro Cell Dev Biol 28A: 763-772.
38. von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeld DA, Yasrgil MG, Wiestler OD (1992). Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77: 295-301.
39. Williams KA, Deber CM (1993). The structure and function of central nervous system myelin. Crit Rev Clin Lab Sci 30: 29-64.
40. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987). Increased expression of the EGF receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899-6903.
41. Yung WKA, Lotan R, Lee P, Lotan D, Steck PA (1989). Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells. Cancer Res 49: 1014-1019.